Firefly Dx

The global PCR market is projected to reach approx. $27.4 billion by 2015, according Research and Markets’ “Polymerase Chain Reaction (PCR) – Products/Tools – A Global Market Watch, 2009-2015″ report.

In addition, there are numerous food safety and agricultural needs for a point-of-need PCR technology. According to Global Industry Analysts Report, Food Safety Testing – A Global Strategic Business Report, The Global market for food safety testing projected to reach $19.7 billion by 2018.

Markets/sample applications for Firefly Dx

Human Infectious Diseases

  • Seasonal and pandemic influenza panels
  • Clostridium difficile test panel
  • True “bed-side” diagnostic capability for respiratory differential diagnostic panels
  • Diarrheal differential diagnostic panels
  • Antibiotic resistance detection panels (such as MRSA)
  • Other emerging and re-emerging concerns such as Ebola, Dengue Fever Virus, Chikungunya, Nipah, etc. in resource constrained environments

Human Clinical (non-infectious disease)

  • Radiation exposure biodosimetry panel post-radiation/nuclear incident and for manned space missions (such as the International Space Station)
  • Cancer detection and diagnostics panels

First Responders

  • Biothreat agent detection and confirmation (such as Anthrax) from environmental samples and powders
  • Radiation/nuclear incident true exposure determination of casualties


  • “Pen-side” diagnostic ability for high-priority and routine animal diseases (such as Porcine Reproductive and Respiratory Syndrome) for veterinarians and animal health technicians
  • Rapid and accurate diagnostics on-site for Foreign Animal Disease outbreaks (such as Foot and Mouth Disease Virus)
  • Field diagnostic capability for high-consequence invasive crop diseases